Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt method replaces rhodium and palladium for carbazole synthesis, offering significant cost reduction and high yields for pharmaceutical intermediates.
Novel Pd-catalyzed synthesis patent CN116640146A offers high efficiency. Reliable supply chain and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN118619879A details a novel Rhodium-catalyzed route for trifluoromethyl enaminones, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113683595B reveals sulfur-promoted triazole synthesis offering safety and cost advantages for pharmaceutical intermediate manufacturing supply chains.
Novel copper-catalyzed method avoids toxic CO and precious metals. Offers high yield and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN113234015B discloses a high-yield one-pot synthesis of 3-acyl dihydroquinolines. This route offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Patent CN104098518B offers azide-free triazole synthesis. Enhances supply chain safety and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN118619879A details a novel Rh-catalyzed C-H activation route for trifluoromethyl enaminones, offering scalable pharmaceutical intermediate solutions with high functional group tolerance.
Patent CN102180794B details a mild, aqueous synthesis of nitrobenzenes from arylboronic acids, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed method for benzofuran derivatives. Reduces complexity and enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110002952B reveals efficient iridium catalysis for alpha,beta-unsaturated alcohols, offering cost-effective pharma intermediate synthesis.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and improves yield for pharmaceutical manufacturing.
Patent CN113045489A details a novel Pd-catalyzed route to quinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113307790B details a metal-free oxidative cyclization for triazoles. This method offers high yields and simplified purification for pharmaceutical supply chains.
Patent CN116730916B reveals a green photocatalytic route for 6-methylphenanthridine. Offers high yield, mild conditions, and supply chain stability for pharmaceutical intermediate manufacturing.
Novel base-promoted synthesis of 5-CF3-1,2,3-triazoles avoiding toxic azides. Offers cost-effective, scalable routes for API intermediates.